Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To be CLEAR - $42M estimate is to PDS - NOT PTSC

TPLs tier pricing strategy is based on first movers in their specified industry paying less than the second company in the same industry purchasing a license after the first company.

Is it a blue light special still? We will soon find out.

GL

Share
New Message
Please login to post a reply